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The life history of dendritic cells (DC) is now established 
from their origins from bone marrow stem cells, their distri-
bution through blood to the tissues, and their movement via 
afferent lymph to lymph nodes for the initiation of immune 
responses. Bone-marrow stem cells, and occasional stem cells 
in peripheral blood (about 1 per 105 mononuclear ce~l~), can 
give rise both to DC and macrophages (MO). In addltlOn to 
stem cells in blood, after short-term culture of mononuclear 
cells, three major morphologic types of DC can be separated 
(types I - III), which probably represent the maturational 
pathway of this cell type; type II cells resemble tissue DC 
such as Langerhans cells and type III have a veiled morphol-
ogy similar to that seen in cells of afferent lymph and in the 
interdigitating cells of the paracortex of lymph nodes. Func-
tionally, DC cultured from peripheral blood are 
T he life history of dendritic cells (DC) has now been described from bone marrow origins, via their pres-ence in peripheral blood, distribution in small num-bers throughout all tissues, and movement via afferent lymphatics to lymph nodes where they are found in 
the para cortex [1,2]. Once distributed through tissues, e.g., as Lan-
gerhans cell s of skin, their importance is established for the acquisi-
tion and processing of antigens [3 - 5]. They then may move 
through the afferent Iymphat.ics into the. lymph nodes where .t1~ey 
become specialized at clustermg and activatmg T cells, recrmtmg 
naive T cells into immune responses [6-8]. Thus their life history, 
migratory properties, and immunologic functions are unique fea-
tures that equip them to be a dispersed out-post of the immune 
system in tissues and yet, having acquired antigens, they may trans-
port them to lymph nodes where they act to localize major events of 
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able to acquire large antigens and process them like Langer-
hans cells of the skin. They can also present antigens to 
stimulate primary T-cell responses, a property associated 
with lymph node DC. In tissues, DC appear to act as outposts 
of the immune system, acquire antigens, and, particularly in 
primary responses, carry the antigens to lymph nodes where 
they initiate T-cell responses. In secondary responses, activa-
tion of memory T cells in the periphery and the acquisition of 
antigen/antibody complexes by follicular dendritic cells of 
the lymph node follicles, which stimulate B cell memory, 
may be more important pathways for immune activation. DC 
may playa role in the development of many immunologic 
diseases including cancer, autoimmunity, and acquired im-
munodeficiency syndrome (AIDS).] Invest DermatoI99:33S-
38S, 1992 
immune activation within lymph nodes. Once established, products 
of this immune activation - memory T cells, cytotoxic cells, 
antibodies - may tackle antigen localized in the tissues, effects that 
may be enhanced by locally produced cascades of Iymphokine pro-
duction. There may be a prerequisite for involvement of DC in 
initial events of immune activation of naive T cells and, even in 
secondary exposure to antigens, DC are potent antigen-presenting 
cells. One major quest in research into DC function is the identifi-
cation of special accessory molecules important to their potency in 
primary stimulation of T cells. 
In this communication an overview of some properties of DC at 
different stages in their development will be discussed, drawing on 
experiments from our laboratories. Some properties of DC in nor-
mal protective immune responses will be described and other exam-
ples where changes in migration and/or function of DC may be 
involved in development of disease will also be discussed, including 
cancer, autoimmunity, and acquired immunodeficiency syndrome 
(AIDS). 
Bone Marrow Origins Development of typical DC with high 
levels of MHC class II molecules has been described in cultures of 
rat bone marrow. These arise from class II negative precursors (see 
[3] for references). Evidence from rodent studies also indicates that 
this cell lineage separates prior to the tissue specific Langerhans cell 
stage. In cultures of human bone marrow in methyl cellulose, colo-
nies of dividing DC develop from stem cells and are identified from 
morphology, phenotype, and function [9]. These bone-marrow 
stem cells were defined as dendritic/Langerhans cell colony-form-
ing units (DL-CFU). More recently, cloning of such cells con-
firmed the earlier suggestion [9] that macrophages (MO) and DC 
can share a common bone marrow stem cell because some joint 
colonies were found . The properties and growth requirements for 
these DL-CFU are now being identified (Reid COL, Tikerpae J, 
Stackpoole AS, personal communication). 
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Figure 1. Type 1 dendritic cell, from human peripheral blood labeled with 
anti - HLA-DR antibody and 20-nm gold particles coated with staphylococ-
cal protein A (see [14] for details). Magnification X 9234. 
Peripheral Blood Dendritic Cells In addition to the presence 
of stem cells in human bone marrow, Reid et al [9] also described the 
presence of low numbers of stem cells in human peripheral blood 
(1 -2 per 105 mononuclear cell s). These stem cells were distinct 
from either the MO or DC also isolated from blood. 
Early reports suggested that around 0.5% of peripheral blood 
mononuclear cells may be DC [10,11]. However, this low figure 
may owe something to difficulties of providing conditions where 
large mononuclear cells develop the densiry allowing their physical 
separation, and of providing an efficient technique for separation. 
The true proportion of DC may be in the region of 2% of mononu-
clear cells. Thus DC cannot be separated by densiry-gradient tech-
niques immediately after isolation of mononuclear cells on ficoll 
gradients and are cultured for some hours first [10 - 12]. Although 
some human DC adhere transiently to plastic most remain non-ad-
herent so that this properry is inappropriate to use for separation of 
human peripheral blood DC. The lack of a specific marker for DC is 
also a problem and, although morphologic identification in wet 
preparations is efficient for a practiced eye, confirmation via a vari-
ery of different phenorypic and functional properties may be neces-
sary [12]. 
The majoriry of DC separated from human peripheral blood 
using hypertonic metrizamide to separate low-densiry cells from 
24-h non-adherent mononuclear cells are highly HLA class II posi-
tive cells of the appearance shown in Fig 1 [13]. These are large 
mononuclear cells with oval or irregular-shaped nuclei, a cytoplasm 
with few organelles and with short veiled projections seen as short 
"dendritic arms" by transmission electron microscopy (rype 1 DC). 
Some DC from peripheral blood have an appearance more closely 
allied to that of skin Langerhans cells with blunter projections (Fig 
2) and described as rype 2 DC. Finally, occasional cells have a 
"veiled" morphology (Fig 3) resembling veiled cells of afferent 
lymphatics or interdigitating cells of the paracortex of lymph nodes 
(Fig 4, rype 3 DC) [13] . 
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The presence in cultured peripheral blood cells of some DC re-
sembling Langerhans cells and others like interdigitating cells sug-
gests that the peripheral blood may contain cells able to mature into 
these cell rypes. They might, therefore, be expected to show the 
properties of acquiring and processing antigens as Langerhans cells 
do l3 - 5] . As evident in Fig 3, cells with an appearance resembling 
Langerhans cells are often found to contain debris indicating a capac-
iry to internalize cellular or other material. More formal evidence 
for the capaciry of some peripheral blood DC to take up particulate 
antigens has been observed by exposing such cells to elementary 
bodies of Chlamydia trachomatis that were previously biotinylated. 
Using the fluorescence-activated cell sorter DC could be identified 
from their large size, lack of labeling with phycoerythrin-labeled 
anti-CD14, and their high levels of labeling with the anti-HLA 
DR [14]. Internalized biotinylated chlamydial antigen was detected 
in a proportion of cells when they were permeabilized with alcohol 
(Stagg AJ, Elsley W, Knight SC, in preparation). The peripheral 
blood DC also shared the capaciry to stimulate primary responses to 
this particulate antigen in vitro. Using DC isolated from cord blood 
and pulsed with elementary bodies of C. trachomatis, or with major 
outer membrane protein of C. trachoma tis (kindly supplied by Prof. 
M. Ward, Southampton Universiry, UK) primary proliferative re-
sponses were stimulated in autologous T lymphocytes (Fig 5). 
The development from peripheral blood DC of cells that resem-
ble morphologically and functionally tissue specific DC such as 
Langerhans cells and those of veiled or interdigitating cells is sug-
gestive evidence that peripheral blood separated DC are precursors 
of cells being distributed into tissues. There is little evidence of 
movement of DC of more mature phenorype from tissues back into 
blood or of movement of DC from lymph nodes into the efferent 
lymph and hence back to blood because few DC are found in normal 
efferent lymph (see [1] for references). It is not known what signals 
are involved in the migration of DC into the tissues or in their 
development into tissue-specific cells. 
Signals involved in migration of DC are likely to be specific 
adhesion molecules involved in distribution to different tissues. 
Figure 2. Type II dendritic cell from human peripheral blood [14]. Magni-
fication X 8100. 
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Figure 3. Type III den?~itic cell isolated fr~m the.synovial fluid of aratiem 
with rheumatoid arthntls [30]. A dendntlc cell IS 111 the center 0 a cell 
cluster. High levels ofHLA-DR round the dendritic cell is seen by immuno-
gold labeling. Magnification X7140. 
However, in considering a possible role for lymphokines involved 
in general migration of DC some studies have examined the adher-
ence of DC to endothelial cells (Brown KA, LeRoy F, Bedford P A, 
Knight SC, in preparation). A higher proportion of DC than of 
lymphocytes adhered to endothelial cells. This a.dherence was sig-
nificantly increased on treatment of the endothelial cells With TNF 
although neither IL-1 nor y-interferon caused a significant change 
in adherence. It is thus possible that TNF contributes a general 
signal for changes in DC migration. 
From Skin to Lymph Nodes The movement of Langerhans 
cells from skin to lymph nodes via afferent lymphatics and the 
increase in this movement following exposure of skin to contact 
sensitizers is now well established from extensive circumstantial 
evidence (see [2,5] for references) . This occurs in humans because an 
increase in cells bearing the CDt marker occurred in human affer-
ent lymph draining the site of exposure following skin painting 
with the contact sensitizer dinitrochlorobenzene (Balfour BM, Per-
eira RA, Edwards A, personal communication). Figure 4 shows a 
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Figure 4. Type III dendritic cell from a mouse lymph node draining the site 
of skin painting with fluorescein isothiocyanate after 90 min. Origin from 
skin Langerhans cell is indicated from Birbeck granules (arrows). Magnifica-
tion X43,000. 
mouse DC isolated from a lymph node draining the site of exposure 
to the contact sensitizer fluorescein isothiocyanate (FITC) and the 
presence ofBirbeck granules in some cells suggests that a proportion 
are derived from Langerhans cells of the skin. One feature of cells of 
the DC lineage following a localized exposure to an antigen is that 
there is an early systemic movement of DC into lymph nodes. Many 
of those in lymph nodes draining the site of exposure carry antigen 
but those at other sites do not carry antigen [15]. The presence of 
antigen in the Langerhans cells is not essential for movement of DC 
into lymph nodes. This observation is also in agreement with earlier 
studies that showed that treatment of mice with cyclosporine A 
around the time of exposure of mice to FITC blocked the acquisi-
tion of antigen by DC although movement of DC into the lymph 
nodes still occurred as in animals not treated with cyclosporine [16]. 
Such experiments provide a precedent for intervention in immune 
responses by drugs at the level of DC as well as suggesting that 
signals other than acquisition of antigen are involved in the migra-
tion of DC from skin to lymph nodes. The nature of the signal 
causing systemic movement of DC is not known although TNF 
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Figure 5. Primary proliferative response to Chlamydia trachomatis. Den-
dritic cells were enriched from 24-h non-adherent mononuclear cells from 
cord blood using a gradient of 13.7% w/v metrizamide in RP~l 1640 
medium (Gibco, UK) with 10% fetal calf serum. The 10w-de'.lSIty ~ells 
(around 30% DC) were pulsed for 2 h with 100 J.lg/ml of a protem eqUlva.-
lent to three quarters of the major outer membrane protem of C. !ra.chomatls 
(kindly supplied by Prof. M. Ward, Southampton, ~K).Cultures m mverted 
Terasaki microplates were 20 J.ll m Dutch modification of RPM1 1640 
medium (Gibco, UK) containing different ~umbers of T cells: Uptake of 
3H-thymidine in a 2-h pulse on day 4 (2 CI mM, 1 J.lg thymldme/ml) IS 
shown [32,34]. 0, T cells only;., T cells + 2000 co'.'trollow-denslty cells; 
0 , T cells + 2000 low-density cells pulsed with antigen. 
alpha may be involved (Kimber et ai, p 48S, this issue). The DC: t?at 
have acquired FITC and are separ~ted. from Iy.mph ~odes dra~mng 
the site of antigen exposure cause slgmfica.n~ s.tll'~Ula~lOn of naive T 
cells in vitro or initiate delayed hypersenslt!vlry III VIVO on transfer 
to normal recipient mice (see [5] for references). . 
More recently the effect of a second exposure to.a co~tact se~sl­
tizer has been studied [17]. If a mouse has been skm-pamted with 
FITC up to a month previously, a second exp.osur~ to .the same 
antigen causes a significantly lower T-cell prohfera~lOn 111 lymph 
nodes than that seen in control animals. In these ammals we have 
shown that acquisition of FITC by DC found within the dra.ining 
nodes is reduced and that these cells show a reduced capaCiry to 
stimulate Tcells in vitro [17]. As suggested, the route of naive T-cell 
stimulation is therefore less important on secondary exposure to 
antigen and evidenc~ of "a,:tigen-induced non-responsiveness" is 
found if this system IS exammed. However,. on secondary exposure 
to contact sensitizers it is known that there IS clustenng of memory 
T cells round Langerhans cells within the skin [18]. Stimulation of 
secondary T-cell responses can also occur via any other cells bearing 
class II molecules (e.g., macrophages). It also seems likely that anti-
gen/antibody complexes may form ~nd th~s~ could be accumulated 
in follicular dendritic cells (FD9 111 .dra~mng lymph node~ [19]' 
The FDC are believed to be denved 111 Situ from fibroblastic ele-
ments within the lymph nodes [20] and therefore represent a diffe~­
ent cell lineage. These are involved in memory B-cell responses via 
stimulation of activated B cells within the lymph nodes [19]. 
In addition to the specific block in antigen acquisition and presen-
tation by DC entering lymph nodes during secondary responses, 
some block in stimulation ofT cells by DC was also seen on expo-
sure to FITC if animals were exposed to an unrelated antigen (oxa-
zalone) 3 - 5 d previously. These DC, h~wever,. acquire . sim~lar 
levels of antigen and no mechamsms for tlus transient non-speCific 
block in antigen presentation is known [17]. 
Dendritic Cell Changes in Disease The involvement of DC 
has been indicated in a number of different diseases involving the 
development of immune responses a.nd some o~ these that have been 
studied in our laboratory will be bnefly mentIOned. 
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Cancer: DC are present within many tumors and may be more 
numerous in tumor tissue than in normal tissue [21]. The role of DC 
in the development of tumor immuniry was examined in experi-
ments using methylcholanthrene-indu~ed tum~rs. in mice. DC 
were pulsed with freeze-dried tumor antigen a,?-d mJe~ted mto nor-
mal mice [22] or were taken from tumor-beanng ammals [23]. In 
each case transfer to normal mice caused protection against chal-
lenge with tumor. By contrast, in tumor-.bearin~ animals there was 
evidence that the development of tumor 11l1mumry may be blocked 
by DC bearing high doses of tumor antigen [22]. Thus, "high dose 
tolerance" may act at the level of the antigen-presenting DC to 
block the development of tumor immuniry. 
A different situation is seen in some T-cell leukemias. Human 
T -cell leukemia virus rype 1 (HTL V -1) may be the causative agent 
not only of T-cell leuke,?-lia it~elf but also of the disease tropical 
spastic paraparesis (TSP), m wluch there IS develop~ent of lIlflam-
matory lesions in the brain [24]. In TSP, one feature IS high "sponta-
neous" proliferation ofT cells [25]. In recent studies (Maca toni a SE, 
Cruickshank K, Rudge P, Knight SC, submitted), when DC were 
removed from the T-cell populations taken from patients with TSP, 
the T-cell proliferation stopped. The proliferation on addition of 
DC back to autologous T cells in vitro was blocked by antibodies to 
class II molecules and to HTL V -1 suggesting that the "spontane-
ous" proliferation in T cells was initiated by persistent presentation 
ofHTLV-1 by DC to stimulate T cells. This was supported by the 
observation that some DC were infected with HTL V -1 as judged by 
in situ hybridization using an HTL V -1 probe. The persistent infec-
tion of DC and stimulation ofT cells may thus be a factor underly-
ing the development of the persistent stimulation of the immune 
system in TSP. Studies suggesting that microglial cells in the brain 
may belong to the DC lineage [26] allow the speculation that pri-
mary antigen-presenting cells infected with HTL V -1 enter the 
brain and cause persistent inflammation at that site. Persistent T-cell 
stimulation by HTLV -1-infected DC might also be involved in the 
development of the T -cell leukemia also associated with HTLV-1. 
Autoimmune Diseases: A mechanism whereby virus-infected DC 
might cause persistent stimulation of T cells and cause autoim-
mune-rype symptoms has already been discussed in the previous 
section. In multiple sclerosis, microglial cells occur round the edges 
of inflammatory lesions in the brain and a role for these cells in 
persistent antigen presentation has been suggested [27]. In an animal 
model of multiple sclerosis, experimental allergic encephalomyeli_ 
tis (EAE), a direct role of DC in the development and persistence of 
disease has been described. Rats with EAE induced with brain anti-
gen in Freund's complete adjuvant were used as donors of DC to 
normal syngeneic recipients. These rats showed symptoms of EAE 
[28]. Similar experiments with thyroglobulin in mice indicated that 
DC exposed to thyroglobulin in vitro or in vivo could initiate the 
development of autoantibodies and Iy~phocyt~ infiltr~tes in the 
thyroid in recipient animals [29]' There IS thus direct eVidence that 
DC with autoantigen can initiate autoimmune diseases. In experi-
mentally induced arthritis in mice, the appearance of DC within the 
joints is an early change [30]. A preliminary event in the develop-
ment of disease may be migration of DC-bearing antigen to an 
inappropriate site. 
The experimental models of autoimmuniry shown to be initiated 
by DC lend importance to the increased numbers of DC found 
within the synovial membrane and fluids in patients with inflamma-
tory arthritis (for references see [31]) (Fig 3). Evidence that the 
antigen-presenting cells enriched for DC are presenting antigen 
came from studies of reactive arthritis that occurs following expo-
sure to genital tract infections with Chlamydia trachomatis (Stagg AS, 
Hughes RA, Keat JA, Knight SC, submitted) . Cell lines specific for 
either C. trachomatis elementary bodies or for PPD were raised from 
peripheral blood of these patients. Enric~ed DC: from joint ~uids , 
but not from peripheral blood, of these patients stimulated prolifera-
tion of the C. trachomatis lines but not the PPD lines, suggesting that 
DC-presenting C. trachomatis are present within the joint fluids . 
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The nature of the signals that cause the accumulation of DC-bear-
ing antigen within the joints are not known although the evidence 
discussed earlier that there may be systemic changes in DC migra-
tion after localized exposure to antigens may contribute to these 
effects. There is non-specific accumulation of memory T cells 
within the joints and it is striking that, although DC from synovial 
fluids will stimulate T cells from peripheral blood to proliferate, 
they fail to stimulate T cells from the joint fl uid, and the block in the 
interaction between memory T cells and DC within the joints re-
quires explanation. Thus, although the precise immunologic events 
at the sites of inflammation still require further explanation there is 
strong circumstantial evidence that DC-bearing antigen may be 
involved in the development of the inflammatory lesions. 
HIV-l Infection: There are two major types of effect of HIV -ion 
the immune system. In the first, there is persistent stimulation of the 
immune system with generalized lymphadenopathy occurring in 
some patients with stimulation of CD8 T cells and persistent anti-
body production. By contrast, there is the catastrophic depletion of 
CD4 T cells and the development of immunodeficiency [32]. We 
have found evidence that infection of DC may underlie both stimu-
latory and suppressive effects of the virus. Studies of infection of DC 
in vitro have demonstrated productive infection of the DC [33 - 35] 
and this infection has been shown to occur in the more mature type 
of DC (i.e., types II and III) [13]. In addition, there are more cells 
containing viral DNA than viral RNA, suggesting that there could 
be latently infected cells. The susceptibility of DC to infection in 
vivo is also evident from reports of infected Langerhans cells (for 
references see [36]) and from studies showing that 2-3 orders of 
magnitude more DC than other types of cells are infected in HIV 
seropositive patients [37]. 
Following the observations of infected DC, we have observed 
twO different types of functional effects of DC infection on the 
immune system. The first is a stimulatory effect causing responses to 
HIV itself and the second is a block in the development of responses 
either to HIV itself or to other antigens. Thus, human DC infected 
with low doses of HI V stimulate primary proliferative and cytotoxic 
T-cell (CTL) responses to HIV in vitro [38]. If DC are used to 
present antigen to T cells from non-immune donors primary CTL 
responses can also be initiated in vitro to peptides of HIV. This 
system can be used to identify potential immunogens for the devel-
opment of vaccines. 
In complete contrast, DC infected with high doses of HIV in 
vitro or in vivo failed to stimulate T-cell responses either to HIV 
itself or to other antigens such as alloantigens or the recall antigens 
influenza or tetanus toxoid [34,37,39]. In early HIV infection in 
vivo, although the function of DC is blocked, macrophages stimu-
late normal levels ofT-cell proliferation to the recall antigens, sug-
gesting that these individuals may be functioning very largely on 
"memory" responses. Defects in primary recruitment of T cells 
could underlie the slow decline in immune responses as memory T 
cells are slowly lost from these patients [39]. The fact that low-level 
infection of DC with HIV allows the stimulation of protective 
immunity to HIV and to other antigens [38] suggests that a ma~or 
aim of therapy may be to reduce viral load to allow such 1~mu111ty 
to develop [40]. Studies of patients treated with zidovudme show 
that DC function is restored by such treatment. It thus appears that 
either deleterious or protective effects may occur through DC in 
HIV infection depending on the dose of virus infecting the cells 
[40]. 
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